Show simple item record

Fluoride Treatment and Risk of Fracture In Osteoporosis Patients

dc.contributor.authorAlshikhi, Sara Almabrouk
dc.descriptionOsteoporosis is common systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk” • More common in postmenopausal Sodium fluoride stimulates bone formation and increases cancellous-bone mass Sodium fluoride (NaF) was currently the only pharmacological agent capable of stimulating bone formation through a direct effect on the osteoblasten_US
dc.publisherfaculty of Basic Medical Science - Libyan International Medical Universityen_US
dc.rightsAttribution 3.0 United States*
dc.titleFluoride Treatment and Risk of Fracture In Osteoporosis Patientsen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States